Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2

Summary: Determining how hematopoietic stem and progenitor cells (HSPCs) can be infected by viruses is necessary to understand and predict how the immune system will drive the host response. We present here a protocol to analyze the capacity of SARS-CoV-2 to infect different subsets of human HSPCs,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hector Huerga Encabo, Rachel Ulferts, Aneesh Sharma, Rupert Beale, Dominique Bonnet
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/c23222a5106946579e969b824591faf8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c23222a5106946579e969b824591faf8
record_format dspace
spelling oai:doaj.org-article:c23222a5106946579e969b824591faf82021-11-14T04:35:36ZInfecting human hematopoietic stem and progenitor cells with SARS-CoV-22666-166710.1016/j.xpro.2021.100903https://doaj.org/article/c23222a5106946579e969b824591faf82021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666166721006092https://doaj.org/toc/2666-1667Summary: Determining how hematopoietic stem and progenitor cells (HSPCs) can be infected by viruses is necessary to understand and predict how the immune system will drive the host response. We present here a protocol to analyze the capacity of SARS-CoV-2 to infect different subsets of human HSPCs, inlcuding procedures for SARS-CoV-2 production and titration, isolation of human HSPCs from different sources (bone marrow, umbilical cord, or peripheral blood), and quantification of SARS-Cov-2 infection capacity by RT-qPCR and colony forming unit assay.For complete details on the use and execution of this protocol, please refer to Huerga Encabo et al. (2021)Hector Huerga EncaboRachel UlfertsAneesh SharmaRupert BealeDominique BonnetElsevierarticleCell BiologyCell isolationCell-based AssaysImmunologyMicrobiologyMicroscopyScience (General)Q1-390ENSTAR Protocols, Vol 2, Iss 4, Pp 100903- (2021)
institution DOAJ
collection DOAJ
language EN
topic Cell Biology
Cell isolation
Cell-based Assays
Immunology
Microbiology
Microscopy
Science (General)
Q1-390
spellingShingle Cell Biology
Cell isolation
Cell-based Assays
Immunology
Microbiology
Microscopy
Science (General)
Q1-390
Hector Huerga Encabo
Rachel Ulferts
Aneesh Sharma
Rupert Beale
Dominique Bonnet
Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
description Summary: Determining how hematopoietic stem and progenitor cells (HSPCs) can be infected by viruses is necessary to understand and predict how the immune system will drive the host response. We present here a protocol to analyze the capacity of SARS-CoV-2 to infect different subsets of human HSPCs, inlcuding procedures for SARS-CoV-2 production and titration, isolation of human HSPCs from different sources (bone marrow, umbilical cord, or peripheral blood), and quantification of SARS-Cov-2 infection capacity by RT-qPCR and colony forming unit assay.For complete details on the use and execution of this protocol, please refer to Huerga Encabo et al. (2021)
format article
author Hector Huerga Encabo
Rachel Ulferts
Aneesh Sharma
Rupert Beale
Dominique Bonnet
author_facet Hector Huerga Encabo
Rachel Ulferts
Aneesh Sharma
Rupert Beale
Dominique Bonnet
author_sort Hector Huerga Encabo
title Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
title_short Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
title_full Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
title_fullStr Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
title_full_unstemmed Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
title_sort infecting human hematopoietic stem and progenitor cells with sars-cov-2
publisher Elsevier
publishDate 2021
url https://doaj.org/article/c23222a5106946579e969b824591faf8
work_keys_str_mv AT hectorhuergaencabo infectinghumanhematopoieticstemandprogenitorcellswithsarscov2
AT rachelulferts infectinghumanhematopoieticstemandprogenitorcellswithsarscov2
AT aneeshsharma infectinghumanhematopoieticstemandprogenitorcellswithsarscov2
AT rupertbeale infectinghumanhematopoieticstemandprogenitorcellswithsarscov2
AT dominiquebonnet infectinghumanhematopoieticstemandprogenitorcellswithsarscov2
_version_ 1718429922264875008